Want to join the conversation?
$XOM's chemical earnings for 2Q16 declined by $29MM to $1.2Bil from 2Q15. Margins increased earnings by $150MM. Volume and mix effects increased earnings by $70MM. All other items decreased earnings by $250MM, due to the absence of asset management gains in the U.S. partly offset by lower expenses.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)